GeoVax Labs Statistics

Total Valuation

GeoVax Labs has a market cap or net worth of $20.95 million. The enterprise value is $12.36 million.

Market Cap	20.95M
Enterprise Value	12.36M

Important Dates

The next estimated earnings date is Thursday, February 27, 2025, after market close.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

GeoVax Labs has 9.44 million shares outstanding. The number of shares has increased by 85.56% in one year.

Current Share Class	9.44M
Shares Outstanding	9.44M
Shares Change (YoY)	+85.56%
Shares Change (QoQ)	+152.17%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	4.76%
Float	8.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.35
Forward PS	1.88
PB Ratio	2.25
P/TBV Ratio	2.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.17

Current Ratio	4.17
Quick Ratio	3.50
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,145.90

Financial Efficiency

Return on equity (ROE) is -276.02% and return on invested capital (ROIC) is -173.73%.

Return on Equity (ROE)	-276.02%
Return on Assets (ROA)	-112.10%
Return on Capital (ROIC)	-173.73%
Revenue Per Employee	$181,774
Profits Per Employee	-$1.43M
Employee Count	17
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.42% in the last 52 weeks. The beta is 3.30, so GeoVax Labs's price volatility has been higher than the market average.

Beta (5Y)	3.30
52-Week Price Change	-55.42%
50-Day Moving Average	2.44
200-Day Moving Average	2.48
Relative Strength Index (RSI)	44.58
Average Volume (20 Days)	759,407

Short Selling Information

The latest short interest is 373,686, so 3.96% of the outstanding shares have been sold short.

Short Interest	373,686
Short Previous Month	511,222
Short % of Shares Out	3.96%
Short % of Float	4.42%
Short Ratio (days to cover)	0.35

Income Statement

In the last 12 months, GeoVax Labs had revenue of $3.09 million and -$24.32 million in losses. Loss per share was -$7.44.

Revenue	3.09M
Gross Profit	-19.25M
Operating Income	-24.49M
Pretax Income	-26.92M
Net Income	-24.32M
EBITDA	-24.40M
EBIT	-24.49M
Loss Per Share	-$7.44

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	8.59M
Total Debt	n/a
Net Cash	8.59M
Net Cash Per Share	$0.91
Equity (Book Value)	8.50M
Book Value Per Share	0.99
Working Capital	8.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.20 million and capital expenditures -$39,602, giving a free cash flow of -$27.24 million.

Operating Cash Flow	-27.20M
Capital Expenditures	-39,602
Free Cash Flow	-27.24M
FCF Per Share	-$2.89

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-792.63%
Pretax Margin	-787.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GeoVax Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-85.56%
Shareholder Yield	-85.56%
Earnings Yield	-116.11%
FCF Yield	-130.03%

Analyst Forecast

The average price target for GeoVax Labs is $14.20, which is 539.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.20
Price Target Difference	539.64%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 31, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Jan 31, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

GeoVax Labs has an Altman Z-Score of -18.84 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.84
Piotroski F-Score	1